China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
18.55
-0.25 (-1.33%)
Feb 28, 2025, 2:44 PM CST
SHA:600062 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 27, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 19,020 | 18,992 | 18,276 | 13,948 | 12,508 | 13,614 | Upgrade
|
Market Cap Growth | 35.18% | 3.92% | 31.03% | 11.51% | -8.12% | 7.94% | Upgrade
|
Enterprise Value | 17,721 | 16,381 | 16,124 | 11,180 | 9,405 | 11,081 | Upgrade
|
Last Close Price | 18.53 | 18.25 | 17.25 | 12.39 | 10.84 | 11.53 | Upgrade
|
PE Ratio | 14.12 | 14.25 | 15.49 | 14.91 | 12.44 | 12.90 | Upgrade
|
Forward PE | 10.83 | 12.46 | 15.32 | 11.70 | 9.97 | 14.94 | Upgrade
|
PS Ratio | 1.84 | 1.86 | 1.90 | 1.53 | 1.47 | 1.45 | Upgrade
|
PB Ratio | 1.87 | 1.61 | 1.61 | 1.33 | 1.33 | 1.57 | Upgrade
|
P/TBV Ratio | 3.34 | 2.24 | 2.29 | 1.76 | 1.69 | 2.04 | Upgrade
|
P/FCF Ratio | 17.58 | 18.50 | 20.54 | 16.42 | 12.36 | 11.36 | Upgrade
|
P/OCF Ratio | 13.30 | 11.65 | 12.91 | 10.40 | 9.20 | 9.46 | Upgrade
|
PEG Ratio | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | Upgrade
|
EV/Sales Ratio | 1.72 | 1.60 | 1.68 | 1.23 | 1.11 | 1.18 | Upgrade
|
EV/EBITDA Ratio | 8.10 | 7.83 | 9.07 | 7.55 | 6.08 | 6.96 | Upgrade
|
EV/EBIT Ratio | 11.89 | 11.09 | 13.03 | 10.81 | 8.02 | 9.00 | Upgrade
|
EV/FCF Ratio | 16.38 | 15.96 | 18.13 | 13.16 | 9.29 | 9.25 | Upgrade
|
Debt / Equity Ratio | 0.07 | 0.03 | 0.03 | 0.01 | - | 0.01 | Upgrade
|
Debt / EBITDA Ratio | 0.34 | 0.15 | 0.16 | 0.04 | - | 0.04 | Upgrade
|
Debt / FCF Ratio | 0.66 | 0.30 | 0.33 | 0.07 | - | 0.05 | Upgrade
|
Asset Turnover | 0.65 | 0.67 | 0.67 | 0.70 | 0.72 | 0.87 | Upgrade
|
Inventory Turnover | 2.82 | 2.66 | 2.42 | 2.74 | 2.59 | 3.26 | Upgrade
|
Quick Ratio | 1.19 | 1.85 | 1.79 | 2.08 | 2.02 | 2.03 | Upgrade
|
Current Ratio | 1.59 | 2.42 | 2.48 | 2.75 | 2.55 | 2.58 | Upgrade
|
Return on Equity (ROE) | 12.07% | 11.47% | 11.32% | 9.79% | 11.23% | 12.86% | Upgrade
|
Return on Assets (ROA) | 5.63% | 6.03% | 5.36% | 4.95% | 6.19% | 7.13% | Upgrade
|
Return on Capital (ROIC) | 7.67% | 7.78% | 6.98% | 6.49% | 8.09% | 9.09% | Upgrade
|
Return on Capital Employed (ROCE) | 11.89% | 12.03% | 10.24% | 9.45% | 12.04% | 13.77% | Upgrade
|
Earnings Yield | 7.09% | 7.02% | 6.46% | 6.71% | 8.04% | 7.75% | Upgrade
|
FCF Yield | 5.69% | 5.40% | 4.87% | 6.09% | 8.09% | 8.80% | Upgrade
|
Dividend Yield | 1.08% | 1.41% | 3.35% | 3.87% | 2.68% | 2.64% | Upgrade
|
Payout Ratio | 83.45% | 22.95% | 67.94% | 32.34% | 31.77% | 28.35% | Upgrade
|
Buyback Yield / Dilution | 0.71% | 0.99% | 0.74% | -0.00% | -0.00% | 0.01% | Upgrade
|
Total Shareholder Return | 1.79% | 2.40% | 4.09% | 3.87% | 2.68% | 2.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.